無翅型MMTV整合位點家族成員3A(WNT3A)多克隆抗體
Polyclonal Antibody to Wingless Type MMTV Integration Site Family, Member 3A (WNT3A)
- 編號PAP155Bo01
- 物種Bos taurus; Bovine (Cattle,牛) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPP155Bo01-無翅型MMTV整合位點家族成員3A(WNT3A)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度0.5mg/ml
- 且適物種Homo sapiens (Human,人)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 832 ¥ 1940 ¥ 2772 ¥ 6930 ¥ 27720
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
特異性
該抗體是針對WNT3A的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別WNT3A。
用法
Western blotting: 0.01-5μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunofluorescence:5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Bos taurus; Bovine (Cattle,牛) | 應用(僅供研究使用,不用于臨床診斷!) |
RPP155Bo01 | 無翅型MMTV整合位點家族成員3A(WNT3A)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAP155Bo01 | 無翅型MMTV整合位點家族成員3A(WNT3A)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻
雜志 | 參考文獻 |
Medical Oncology | Wls promotes the proliferation of breast cancer cells via Wnt signaling [Pubmed:25801232] |
J Histochem Cytochem | Wnt3a Mediates the Inhibitory Effect of Hyperoxia on the Transdifferentiation of AECIIs to AECIs [PubMed: 26209081] |
PloS one | Gelatin device for the delivery of growth factors involved in endochondral ossification [pubmed:28380024] |
Life Sciences | Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways. [pubmed:28754618] |
Oxidative Medicine and Cellular Longevity | Secreted Frizzled-Related Protein-2 Inhibits Doxorubicin Induced Apoptosis Mediated Through the Akt-mTOR Pathway in Soleus Muscle [Pubmed:30151071] |
The Showa University Journal of Medical Sciences | Eribulin Treatment Induces High Expression of miR-195 and Inactivates the Wnt/β-catenin Signaling Pathway in Triple-negative Breast Cancer [Doi: 10.15369/sujms.30.359] |
Journal of Cancer | Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma [Pubmed: 31737122] |
CANCER LETTERS | Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection [Pubmed: 32920199] |
Biomaterials | An improved osseointegration of metal implants by pitavastatin loaded multilayer films with osteogenic and angiogenic properties [34823885] |
留言咨詢